Episode #2
FDA Approved Doesn't Always Mean Preferred
Sep 14, 20265 minS1
<p>FDA approved doesn’t always mean preferred, and off-label doesn’t automatically mean unsupported.</p><p>In this episode of The Oncology Minute, I break down one of the most important distinctions in oncology treatment decision-making: the difference between FDA approval and where a therapy actually fits in current clinical practice.</p><p>FDA approval tells us that a drug has demonstrated safety and efficacy for a specific indication. But in oncology, that is often only one piece of the picture. Clinical guidelines, trial data, biomarkers, prior therapy, line of treatment, histology, performance status, and the individual patient all influ...
